AACR meeting 2016

The American Association for Research on Cancer (AACR) annual meeting took place last week in New Orleans, involving close to 20,000 participants covering academia, government organisations, charities and private industry. Quite a few Epicentre colleagues were at the AACR this year, and had some interesting post-meeting thoughts. For those who have participated in previous AACR […]

New cancer ‘moonshot’ by President Obama, and Illumina takes up early detection of cancer

This week saw the last of the State of the Union addresses by President Obama, and those of us at EPICentre were gladdened by the priority he gave to cancer. In stirring words he talked of ‘For the loved ones we have all lost, for the family we can still save, let’s make America the […]

Does urine hold the key to a pancreatic cancer test?

For a variety of reasons, including a lack of tests to detect pancreatic cancer in its early treatable forms and the poor performance of current treatments, pancreatic cancer has one of the poorest survival of all cancers – sadly, with many patients dying within months of diagnosis. Thus, the search for new tests to identify […]

Good news for research into early detection of cancer

Of the 14,000,000 cancer cases that occur globally each year, over half will eventually die from their disease, usually within 5 years of diagnosis. Even though there is much excitement about new treatments for cancer that target specific genomic aspects of the tumour (so called personalised medicines) it is hard to envisage how this strategy […]